Super Bakers (I) (530735)
Slow GrowerScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹30.45 |
| Market Cap | ₹9.53 Cr |
| P/E Ratio | 20.43 |
| ROCE | 10.2% |
| ROE | 9.87% |
| Dividend Yield | 0% |
| Profit Growth | 20% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹28.5 — ₹38.11 |
| Sector | Food Products |
| Book Value | ₹17.01 |
Strengths
- Profitable in absolute terms: P/E of 20.43 implies annual earnings of roughly ₹0.49 Cr on a ₹10 Cr market cap.
- ROE of 9.87% and ROCE of 10.20% show the business is generating modest positive returns on capital.
- Piotroski F-Score of 6/9 suggests decent financial health and no obvious accounting red flags from the available data.
- Book value of ₹17.01 per share gives tangible asset backing, with P/B of 1.79 not an extreme premium.
Concerns
- Latest quarter has zero reported sales and zero net profit, making the ongoing operating story unverifiable.
- Sales growth is 0.00%, while packaged foods is a low-margin, intensely competitive industry.
- Dividend yield is 0.00%, so shareholders receive no income while waiting for uncertain growth.
- Promoter holding is N/A and debt/equity is N/A; poor disclosure in a micro-cap raises governance risk.
AI Analysis
Let me evaluate what I can actually verify. Super Bakers is a ₹10 crore micro-cap in packaged foods, selling at ₹30.45 with a P/E of 20.43. That price implies the market pays about ₹20 for every ₹1 of current earnings, while return on equity is just 9.87% and ROCE is 10.20%. Those are not terrible numbers, but they are not wonderful either. For a business with zero sales growth, no dividend, and a latest quarter showing zero sales and zero net profit, I need an unusually large margin of safety. I do not see one. I like the 20% profit growth and the PEG ratio of 1.02, but I cannot trust growth on a base this tiny, especially when top-line growth is flat. Packaged foods is a brutally competitive commodity-like industry; a small player without pricing power or a dominant franchise is likely a price-taker. The Piotroski score of 6/9 is reassuring, and book value of ₹17.01 per share means I am paying only 1.79 times stated equity, so the balance sheet is not my main fear. My fear is that the operations are dormant: zero reported quarterly sales and profit, promoter holding not disclosed, and debt/equity not available. A Graham buyer would demand transparency, a record of earnings, and a cushion; all three are missing here. The stock is near the middle of its 52-week range, so there is no distress-induced bargain price either. This is, at best, a small, ordinary slow grower; at worst, a shell. I will watch it, not own it.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer